EPISODE · Feb 22, 2022 · 36 MIN
A review of Cabenuva®, an antiretroviral agent for HIV.
Dr. Rupeena Purewal invites special guest Saskatoon pharmacist Carley Pozniak to review Cabenuva®, an antiretroviral agent for HIV. Cabenuva® (Cabotegravir Extended Release Injectable Suspension) has been approved in 2020 for medical use in Canada.
Embed this episode
Ready to play
A review of Cabenuva®, an antiretroviral agent for HIV.
0:00
36:02
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of The Canadian Breakpoint?
This episode is 36 minutes long.
When was this The Canadian Breakpoint episode published?
This episode was published on February 22, 2022.
Is there a transcript available for this episode?
Yes, a full transcript is available for this episode. You can read the complete transcript on the episode page.
Can I download this The Canadian Breakpoint episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!